Edesa Biotech Statistics Share Statistics Edesa Biotech has 7.04M
shares outstanding. The number of shares has increased by 102.89%
in one year.
Shares Outstanding 7.04M Shares Change (YoY) 102.89% Shares Change (QoQ) 0.19% Owned by Institutions (%) 53.19% Shares Floating 5.35M Failed to Deliver (FTD) Shares 2 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 6.9K, so 0.09% of the outstanding
shares have been sold short.
Short Interest 6.9K Short % of Shares Out 0.09% Short % of Float 0.11% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.31 and the forward
PE ratio is -1.39.
Edesa Biotech's PEG ratio is
0.07.
PE Ratio -2.31 Forward PE -1.39 PS Ratio 0 Forward PS n/a PB Ratio 7.18 P/FCF Ratio -2.91 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Edesa Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.91,
with a Debt / Equity ratio of 0.01.
Current Ratio 0.91 Quick Ratio 0.91 Debt / Equity 0.01 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-385.63K Employee Count 16 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 800 Effective Tax Rate -0.01%
Stock Price Statistics The stock price has increased by -35.6% in the
last 52 weeks. The beta is 0.07, so Edesa Biotech's
price volatility has been higher than the market average.
Beta 0.07 52-Week Price Change -35.6% 50-Day Moving Average 2.36 200-Day Moving Average 2.18 Relative Strength Index (RSI) 69.13 Average Volume (20 Days) 51,269
Income Statement
Revenue n/a Gross Profit -186.05K Operating Income -7.01M Net Income -6.17M EBITDA -5.98M EBIT -6.17M Earnings Per Share (EPS) -1.93
Full Income Statement Balance Sheet The company has 1.04M in cash and 19.87K in
debt, giving a net cash position of 1.02M.
Cash & Cash Equivalents 1.04M Total Debt 19.87K Net Cash 1.02M Retained Earnings -58.59M Total Assets 14.8M Working Capital 12.09M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.89M
and capital expenditures 0, giving a free cash flow of -4.89M.
Operating Cash Flow -4.89M Capital Expenditures n/a Free Cash Flow -4.89M FCF Per Share -1.53
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields EDSA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for EDSA is $5,
which is 81.8% higher than the current price. The consensus rating is "Buy".
Price Target $5 Price Target Difference 81.8% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 11, 2023. It was a
backward
split with a ratio of 1:7.
Last Split Date Oct 11, 2023 Split Type backward Split Ratio 1:7
Scores Altman Z-Score 8.94 Piotroski F-Score 2
